Examkin

Question

Difficulty: HardInfectious Diseases

Evaluate the following clinical scenarios of patients diagnosed with infective endocarditis. Pair each patient profile with the most appropriate definitive antimicrobial regimen based on current treatment guidelines.

  • A 68-year-old man with newly diagnosed colon adenocarcinoma who develops native valve endocarditis. Blood cultures are positive for Streptococcus gallolyticus.Intravenous ceftriaxone monotherapy
  • A 55-year-old woman who underwent mechanical mitral valve replacement 45 days ago and now has echocardiogram-confirmed endocarditis. Blood cultures grow methicillin-resistant Staphylococcus epidermidis.Intravenous vancomycin, oral rifampin, and intravenous gentamicin
  • A 72-year-old man with benign prostatic hyperplasia who develops native aortic valve endocarditis. Blood cultures grow Enterococcus faecalis demonstrating high-level resistance to gentamicin.Intravenous ampicillin and intravenous ceftriaxone
  • A 40-year-old sheep farmer with culture-negative endocarditis, hepatomegaly, and significantly elevated phase I IgG titers against Coxiella burnetii.Oral doxycycline and oral hydroxychloroquine

Answer

The correct pairings match each specific pathogen and host profile with its guideline-directed antimicrobial therapy: S. gallolyticus is treated with ceftriaxone; early prosthetic valve S. epidermidis requires vancomycin, rifampin, and gentamicin; E. faecalis with high-level aminoglycoside resistance requires ampicillin and ceftriaxone; and Q fever endocarditis is treated with doxycycline and hydroxychloroquine.
Each pairing reflects the guideline-directed medical therapy for specific subtypes of infective endocarditis. Streptococcus gallolyticus, strongly associated with colonic malignancy, is highly susceptible and effectively treated with ceftriaxone monotherapy. Early prosthetic valve endocarditis caused by methicillin-resistant Staphylococcus epidermidis requires a triple regimen of vancomycin, rifampin (vital for biofilm eradication), and gentamicin (for initial synergy). For Enterococcus faecalis with high-level aminoglycoside resistance, the standard synergy with gentamicin is ineffective; therefore, dual beta-lactam therapy using ampicillin and ceftriaxone is utilized to achieve synergistic bactericidal activity via differential penicillin-binding protein saturation. Finally, Coxiella burnetii causes culture-negative endocarditis that requires treatment with doxycycline and hydroxychloroquine; the latter alkalinizes the acidic phagolysosome where the bacteria reside, allowing doxycycline to effectively kill the pathogen.

Step-by-Step Solution

1
Analyze the first patient with Streptococcus gallolyticus native valve endocarditis.
Identified as a highly penicillin-susceptible streptococcus.
Penicillin G or ceftriaxone monotherapy is the standard of care for highly susceptible streptococcal strains causing native valve endocarditis.
2
Evaluate the second patient with early (less than 2 months) prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Identified the need for broad-spectrum anti-staphylococcal therapy with biofilm penetration and synergistic coverage.
The standard regimen for staphylococcal prosthetic valve endocarditis includes vancomycin (for methicillin resistance), rifampin (essential for sterilizing biofilms on prosthetic material), and gentamicin (for early synergy).
3
Assess the third patient with Enterococcus faecalis demonstrating high-level aminoglycoside resistance (HLAR).
Determined that standard ampicillin-gentamicin synergy cannot be utilized.
Ampicillin combined with ceftriaxone provides synergistic bactericidal activity through complementary binding of different penicillin-binding proteins (PBPs), overcoming the limitation imposed by HLAR.
4
Review the fourth patient with Coxiella burnetii (Q fever) culture-negative endocarditis.
Identified an intracellular pathogen requiring specialized combination therapy.
Q fever endocarditis requires prolonged therapy with doxycycline and hydroxychloroquine, as hydroxychloroquine raises the pH of the phagolysosome, rendering doxycycline bactericidal in that environment.

Key Concept

Definitive antimicrobial therapy for infective endocarditis is tailored to the specific pathogen's resistance mechanisms (e.g., HLAR), the presence of prosthetic material requiring biofilm eradication, and whether the organism is intracellular.
Rate this question

Topics

Infectious Diseases

More questions from this topic